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Abstract
Introduction: Re-feeding syndrome is common in patients with long-term starvation. To the best of our
knowledge this case is the first to report a patient with short bowel syndrome developing re-feeding syndrome 12
years after the bowel resection.
Case presentation: A 33-year-old Chinese Han man underwent small bowel resection leaving only 40 cm of
bowel, without an ileocecal valve, 12 years previously. At that time he was weaned from total parenteral nutrition
and had a normal diet. He later developed features of severe malnutrition, and when parenteral nutrition was
given, he developed re-feeding syndrome.
Conclusion: Although re-feeding syndrome is a common complication in patients with any kind of nutritional
support, and known to us for many years, high risk patients still need more attention and monitoring. Re-feeding
syndrome in this case was not only a macronutrients deficiency but also a micronutrient deficient, and prompt
supplement therapy and organ function support proved to be successful.
Introduction
People are at great risk of re-feeding syndrome (RFS)
when they are severely malnourished at the time of re-
feeding. RFS usually occurs during the early stage of oral,
enteral or parenteral feeding. To illustrate the awareness
of RFS we report a case of RFS secondary to short bowel
syndrome (SBS).
Case presentation
A 33-year-old man was admitted to our hospital because
of generalized weakness, emaciation and anorexia 12
years after massive small bowel resection. Our patient
underwent massive small bowel and ileocecal resection
because of small bowel volvulus 12 years ago. An end-to-
side anastomosis was performed between his proximal
jejunum and his ascending colon, with only 40 cm of his
small bowel remaining. Subsequent bowel rehabilitation
therapy, which included enteral nutrition with dietary
fiber, recombinant human growth hormone and gluta-
mine, was instituted for four weeks [1]. Our patient was
weaned from total parenteral nutrition (TPN) and had a
normal diet up to the present.
One month ago, our patient developed diarrhea and
weight loss of 7 kg with no obvious predisposing cause; he
felt weak, anorexic and dizzy, and became progressively
cachexic. Urinary volume was reduced, while stool volume
was increased. On admission, our patient’s body weight
was 36 kg, body mass index (BMI) 12.2 kg/m2, heart rate
80 beats per minute (bpm), blood pressure 70/50 mmHg,
and respiratory rate 18 bpm. He was oriented and cogni-
tively intact. Pitting edema appeared in his lower extremi-
ties. An abdominal examination revealed previous surgery
scarring, thin skin, a scaphoid abdomen, and negative
shifting dullness. A chest X-ray showed a high density sha-
dow of a nodule outside his right upper lung, considered
to be rib calcification. A lower limb X-ray and ultrasound
of both kidneys and ureters were normal. An ultrasound
of his gallbladder showed gallbladder atrophy. An electro-
cardiogram showed normal sinus rhythm with T wave
changes (II/III/avF/v4-6 flat, inversion), with incomplete
right bundle branch block. All laboratory values are pre-
sented in Table 1.* Correspondence: drweimingzhu@yahoo.com.cn
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Our patient was diagnosed with severe malnutrition and
was supported by blood transfusion, parenteral nutrition
(500 kcal/day), fluid, electrolyte, trace element and multi-
vitamin supplementation (one ampoule each of Soluvit®
and Addamel® daily), along with thiamine 100 mg intrave-
nously prophylactically. Our patient’s physical strength
improved after these treatments, and pitting edema of the
lower extremities decreased. Within 24 hours, our patient
presented with profound fatigue and flaccid weakness of
all four limbs. His heart rate was 98 bpm, respiration was
normal, but biochemical investigation showed severe
hypophosphatemia 0.05 mmol/L (Table 1), hence a clinical
diagnosis of RFS was made, and immediately the patient
was transferred to the intensive care unit (ICU) for closer
monitoring. Parenteral and enteral nutrition were inter-
rupted and intravenous supplementation with phosphate
polyfusor (120 mmol on the first day, then 60 mmol per
day intravenously or enterally for five days) was initiated,
along with enteral and parenteral multi-vitamins and trace
elements (two ampoules each of Soluvit®, Vitalipid® and
Addamel® daily for two days, thereafter one ampoule of
each daily). He also received a once daily intramuscular
dose of Vitamin B12 0.1 mg and thiamine 100 mg. In
addition, a hydrocortisone injection 100 mg was given to
prevent adrenal insufficiency on the fifth day. A plasma
transfusion was given to expand blood volume because
blood pressure fell to 97/60 mmHg temporarily.
On the seventh day, our patient had numbness of his
limbs, diarrhea and dyspnea. At the same time, a chest
X-ray indicated right middle lobe pneumonia. Respiratory
muscle weakness was considered to be the reason, and an
emergency tracheotomy with mechanical ventilation was
done, and sputum aspiration was regularly performed.
Anti-diarrhea (diphenoxylate 1 pill three times a day by
mouth), anti-infection (moxifloxacin 0.4 g/day intrave-
nously), and antacid (omeprazole 40 mg intravenously
twice daily) therapy were given immediately.
On the ninth day, when his blood chemistry became
normal, enteral nutrition was resumed at 500 kcal/day
and increased gradually. On the twelfth day, total enteral
nutrition was well tolerated with improved pulmonary
symptoms, and our patient was successfully weaned
from mechanical ventilator support. Subsequently, he
received recombinant human growth hormone therapy
(10 u/d) and total enteral nutritional support for one
month and recovered uneventfully with a weight of
45 kg (gain of 9 kg) and a BMI of 15.2 kg/m2.
Discussion
RFS was first recognized in post-World War II prisoners
[2]; the exact incidence is unknown, but extremely mal-
nourished patients are a susceptible population [3]. It is
reported that 25% of cancer patients receiving TPN present
with hypophosphatemia [4,5], and in severely malnourished
cancer patients, the incidence of hypophosphatemia may
go up to 100% [6].
The clinical presentation of re-feeding syndrome is char-
acterized by fluid and electrolyte disturbance, which is
caused by a shift of electrolytes and vitamins from extra-
cellular space during starvation to intracellular space after
re-feeding with glucose and amino acids [3]. Cellular
uptake of glucose and amino acids during anabolism
increases insulin secretion, causing increased cellular
uptake of phosphate, potassium, magnesium and thiamine.
This leads to a dramatic depletion of serum levels of these
elements, which are the laboratory findings of re-feeding
syndrome. Hypophosphatemia appears to be the predomi-
nant manifestation of RFS [7].
Re-feeding syndrome can be asymptomatic during the
prodromal stage; as a result, it may be overlooked if the
physicians are not aware of the risk or do not evaluate
the electrolyte levels frequently [8]. Besides abnormalities
in serum levels of glucose and electrolytes, RFS patients
may also manifest symptoms from various systems,
Table 1 Laboratory values
Lab Values Normal Initial Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 18
Phosphate, mmol/L 0.7-1.5 1.10 0.25 0.05 0.09 0.50 1.10 1.31 0.91 1.73
Potassium, mmol/L 3.5-5.5 3.1 3.1 4.9 5.5 3.9 3.2 3.4 4.2 4.8
Sodium, mmol/L 136-148 144 145 145 144 135 138 148 147 144
Glucose, mmol/L 3.9-6.2 6.0 3.5 7.7 5.2 8.9 5.2 6.3 6.8 5.0
Magnesium, mmol/L 0.6-1.0 0.60 0.57 0.76 0.73 0.50 0.60 0.66 0.92 0.91
Calcium, mmol/L 2.1-2.6 1.7 2.1 2.0 2.3 2.0 2.1 2.3 2.3 2.4
Albumin, g/L 35-55 27.7 27.6 30.0 32.4 32.3 31.4 37.7
Prealbumin, mg/dL 250-400 100 161 196 125 116 209
Hemaglobin, g/L 120-160 48 62 97 100 104 102 84 97 98
Hematocrit, % 45-50 14.0 18.1 28.6 30.5 31.5 30.3 25.5 28.6 29.8
blood urea nitrogen, mmol/L 2.9-7.5 5.0 5.2 2.8 6.9 6.0 8.4 11.1 9.8
Creatine, mg/dL 45-110 86 68 86 67 49 152 70 46
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including the cardiovascular, pulmonary, neuromuscular
and hematologic systems [3,9].
Re-feeding syndrome is diagnosed by a history of
severe malnutrition and re-feeding, the clinical symp-
toms of cardiovascular, respiratory, neurological or ske-
letomuscular systems, hypo- or hyperglycemia, and the
abnormalities of fluid and electrolytes [4,7,10,11]. A dif-
ferential diagnosis should be considered; including
hemodialysis, diabetic ketoacidosis, sepsis, volume reple-
tion, malabsorption and multiple medication usage, but
treatment must be initiated early because of the high
mortality rate after delayed diagnosis. Repletion of elec-
trolytes (including trace elements) and multi-vitamins
(including thiamine, vitamin B12) intravenously to
maintain a normal blood level of these elements must
be initiated early, before nutritional support can be
started. A simple supplementation of individual ele-
ments (for example, phosphorus or potassium) or cor-
rection of hypoglycemia is not effective. Symptomatic
treatment to support the vital signs, such as tracheot-
omy and mechanical ventilation, is also important for
the treatment success in the patient.
Because of the high mortality associated with RFS,
assessing risk and an early awareness of RFS in mal-
nourished patients is much more important than treat-
ment after symptom attack [12]. For the high risk
patient, nutrition should be given after sufficient supple-
mentation with electrolytes (including trace elements)
and multi-vitamins (including thiamine), and should be
initiated at a low calorie level (about 30% of require-
ments), and slowly increased.
This case illustrates the vulnerability of SBS patients
with rapid weight loss and an extremely low BMI to
RFS. This patient had only 40 cm of small bowel with
no ileocecal valve remaining, which predisposed him to
severe malnutrition. Although serum levels of electro-
lytes were normal on admission, our patient developed
RFS after initiation of parental nutrition, which switched
his metabolic state from low catabolism to anabolism. A
rapid shift of electrolytes (especially phosphate P+,
potassium K+ and magnesium Mg2+) occurred from
plasma to intracellular space, leading to a sharp decrease
of plasma levels of these elements. Our patient also suf-
fered hypotension, dyspnea, pneumonia, flaccid paralysis
and lethargy during the course of the disease. Parental
nutrition was withdrawn immediately after the onset of
the symptoms, and a sufficient amount of electrolytes
and multi-vitamins were initiated intravenously and
promptly based on a careful monitoring of their levels.
Our patient was transferred to the intensive care unit,
thus ensuring close monitoring. The key management
was emergency tracheotomy with mechanical ventilation
to prevent hypoxemia and acute respiratory failure.
Conclusion
Clinicians should still be aware of the high risks and
complications of RFS, whether the nutritional support is
oral, enteral, or parenteral. Special attention should be
paid to the early correction of not only macronutrients
(potassium, phosphate, magnesium and thiamine), but
also micronutrients like trace elements and vitamins,
before nutritional support can be initiated. Organ func-
tion support should be initiated without hesitation once
any symptom or sign of organ dysfunction emerges.
Early monitoring and prophylactic supplement could
prevent RFS. Although prompt supportive management
could reverse the deterioration, careful recognition of
patients at risk is still crucial for clinicians and the
nutrition team.
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